Grace Almendras Castillo

GRACE ALMENDRAS CASTILLO London, United Kingdom | [email protected] +4407733179419 https://uk.linkedin.com/in/gracealmendrascastillo EXECUTIVE PROFILE Strategic, mission-driven leader with over 20 years of international experience in life sciences, AI-powered venture building, and impact entrepreneurship. Recognized for transforming health insights into commercially viable, data-driven ventures that improve patient lives and democratize access to funding and innovation. Proven track record in launching AI and digital health platforms, building global ecosystems, and scaling research-backed products from concept to commercialization. Founder of two companies, including a successful exit in digital health. Currently focused on AI + Health Innovation + Impact Entrepreneurship with cross-sector experience in biotech, patient engagement, women’s health, mental health, and preventative health models for emerging and underserved markets. CORE COMPETENCIES Health Innovation Strategy (Preventative, Chronic, Community-Based) Data-Driven Decision Frameworks (ML, NLP, Readiness Scoring) AI/Data Science in Health, Climate & Life Sciences Impact Venture Building & Innovation Commercialization Ecosystem Design: Research, SMEs, Investors, Academia Women’s Health, Mental Health, Aging & Longevity Capital Access Strategy for Underrepresented Founders Cross-Sector Partnerships: Philanthropy, Industry, Government Data-Driven Decision Frameworks (ML, NLP, Readiness Scoring) CURRENT ROLE Founder & CEO, Gifftid AI (UK, Global) 2023–Present Building an AI-powered data and intelligence infrastructure to scale growth and impact-driven SMEs across health, biotech, climate, and life sciences. Gifftid uses real-world performance, impact, and investor-readiness analytics to match companies with capital, commercial opportunities, and ecosystems. Developed the Gifftid Readiness & Impact Scoring System for early-stage health and climate ventures Built partnerships across UK, Africa, and Asia to drive inclusive innovation Launched Impact Builder Network and data platform for capital deployment Built tools for underrepresented founders to generate impact evidence and access investment PREVIOUS EXPERIENCE Founder & CEO, Self Care Catalysts (Canada/US) 2010–2022 – Acquired A digital health company focused on patient experience, chronic disease, and behavioral health analytics. Invented and patented Health Storylines, a platform for real-world data in chronic health conditions Partnered with global life science companies (Pfizer, UCB, Takeda, AstraZeneca) Scaled platform across North America in cancer, MS, mental health, and rare diseases Successfully exited to a healthcare consulting and data company in the US Global Marketing , Product Launches, Innovation , Life Sciences, Consumer Health, Nutrition Sectors Various Roles corporate and consulting roles , Novartis, Johnson & Johnson, Procter & Gamble, Pfizer Led multi-million-dollar product portfolios in consumer healthcare and life sciences Commercialized new science-backed products across neurology, cardiovascular, and immune categories Lived/worked across Asia, Canada, and UK VENTURE & ADVOCACY INITIATIVES Boundless (Author, September 2025): A book on neurodiversity, resilience, and entrepreneurship as a path to self-realization and societal contribution Healthcare Co-op Network in Africa: Designing AI/data infrastructure to scale decentralized clinical research and preventative health models Mental Health + Digital Economy Program (UK): Collaborating with MQ Research, TechUK, and impact institutions to build new models for emerging adults’ mental wellbeing EDUCATION Oxford University (SBS) – Impact Investing. Impact Management and Social Finance Yale School of Management – Sustainable Finance Wharton Executive Education – Leadership & Strategy Rotman School of Management – Entrepreneurship University of the Philippines – Bachelor of Science HRA INTELLECTUAL PROPERTY Patented: Health Storylines platform – US and international patents for chronic disease real-world data capture Provisional Patent Filed: Gifftid AI platform for SME readiness scoring, investor matching, and capital deployment